Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-30 to 2025-07-01
Current total value of award: $6451.23
Description: 4568676361!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML